Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature
- PMID: 11765186
- DOI: 10.1177/030089160108700513
Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature
Abstract
Carbohydrate antigen CA19-9 is commonly used in the diagnosis of pancreatic and biliary malignancies. However, increases in its level in benign conditions such as acute cholangitis or pancreatitis have also been reported. A 79-year-old woman presented with cholangitis and a pancreatic pseudocyst while showing elevation of CA19-9 up to 35,500 U/mL. The patient was adequately treated and at two months' follow-up the CA19-9 level had returned to normal.
Similar articles
-
Extremely elevated CA19-9 in acute cholangitis.Dig Dis Sci. 2007 Nov;52(11):3140-2. doi: 10.1007/s10620-006-9164-7. Epub 2007 Apr 3. Dig Dis Sci. 2007. PMID: 17404889
-
A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.Am J Gastroenterol. 1999 Jul;94(7):1941-6. doi: 10.1111/j.1572-0241.1999.01234.x. Am J Gastroenterol. 1999. PMID: 10406263
-
Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis.Clin Gastroenterol Hepatol. 2015 Dec;13(13):2372-9. doi: 10.1016/j.cgh.2015.07.014. Epub 2015 Jul 17. Clin Gastroenterol Hepatol. 2015. PMID: 26192140
-
Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature.Turk J Gastroenterol. 2010 Dec;21(4):461-3. doi: 10.4318/tjg.2010.0139. Turk J Gastroenterol. 2010. PMID: 21332006 Review.
-
[CA19-9 has no value as a tumor marker in obstructive jaundice].Schweiz Med Wochenschr. 1999 Jan 23;129(3):77-9. Schweiz Med Wochenschr. 1999. PMID: 10065510 Review. German.
Cited by
-
Clinical diagnosis and staging of cholangiocarcinoma.Nat Rev Gastroenterol Hepatol. 2011 Aug 2;8(9):512-22. doi: 10.1038/nrgastro.2011.131. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21808282 Free PMC article. Review.
-
CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer.Tumour Biol. 2012 Jun;33(3):799-807. doi: 10.1007/s13277-011-0297-8. Epub 2011 Dec 29. Tumour Biol. 2012. PMID: 22203495
-
Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Biomed Res Int. 2013;2013:783131. doi: 10.1155/2013/783131. Epub 2013 Mar 17. Biomed Res Int. 2013. PMID: 23586059 Free PMC article. Review.
-
High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker.Med Oncol. 2012 Sep;29(3):1886-91. doi: 10.1007/s12032-011-0058-y. Epub 2011 Sep 13. Med Oncol. 2012. PMID: 21912994
-
Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma.Cancer Sci. 2011 Sep;102(9):1673-9. doi: 10.1111/j.1349-7006.2011.01989.x. Epub 2011 Jul 3. Cancer Sci. 2011. PMID: 21615621 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources